Home > > > Report Detail

Global Antiviral Drugs Market (By Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Publisher Name :
Date: 20-May-2020
No. of pages: 121
Inquire Before Buying

The global antiviral drugs market is expected to reach US$70.95 billion in 2024, increasing at a CAGR of 2.10%, for the duration of 2020-2024. The factors such as, increasing prevalence of HIV infections, upswing in international tourism, growth in geriatric population, increasing pharmaceutical R&D spending, rapid urbanization, upsurge in healthcare spending and growing awareness about various viral diseases are expected to drive the growth of the market. However, the market growth would be challenged by high cost involves in drug development, threats associated with drug counterfeiting and stringent government regulations. A few notable trends may include accelerating growth rate of infectious diseases, increasing focus on telehealth, growth in pharmaceutical Merger & acquisitions and emergence of new infectious diseases.

The global antiviral drugs market is fragmented into branded drugs and generic drugs. Branded drugs dominate the market owing to the increased levels of trust and reliability associated with branded pharmaceutical companies among customers. However, generic drugs are also gaining widespread popularity among customers due to the low cost factor, which is likely to raise its share in global market in coming years.

The fastest growing regional market was North America owing to the presence of key players in the region, availability of sophisticated healthcare infrastructure and increasing awareness of viral diseases among people. Whereas, Europe and Asia Pacific also contributed to significant shares in the global market due to the factors such as increase in patient pool of various infectious diseases and rise in the acceptance of generic drugs. However, the sudden outbreak of COVID-19 has caused a major disruption all across the world, which is leading to the massive demand for antiviral drugs for the management of infected coronavirus patients, providing the growth opportunity to the market globally.

Scope of the report:


  • The report provides a comprehensive analysis of the global antiviral drugs market.

  • The major regional markets (North America, Europe, Asia-Pacific Middle East & Africa) have been analyzed.

  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players (Johnson & Johnson, Merck & Co., AbbVie Inc., Bristol-Myer Squibb, Gilead Sciences and Cipla) are also presented in detail.


Key Target Audience:


  • Antiviral Drugs Manufacturers

  • Pharmaceuticals and Biopharmaceutical Firms

  • End Users (Hospitals, Clinics, Pharmacies, Drugs Stores, etc.)

  • Investment Banks

  • Healthcare and Medical Consultants

  • Government Bodies & Regulating Authorities

Global Antiviral Drugs Market (By Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Table of Contents

1. Overview
1.1 Introduction
1.2 Viral Life Cycle
1.3 Antiviral Agents
1.4 Development of Antiviral Drugs
1.5 Some Major Antiviral Compounds

2. Impact of COVID-19
2.1 Rise in COVID-19 Death Toll
2.2 Growth in Government Spending on Healthcare
2.3 COVID-19 Antiviral Candidate Drugs in Trial
2.4 Regional Impact

3. Remdesivir and COVID-19
3.1 Remdesivir
3.2 Major Clinical Studies of Remdesivir
3.3 Emergency Use of Remdesivir

4. Global Market Analysis
4.1 Global Antiviral Drugs Market by Value
4.2 Global Antiviral Drugs Market Forecast by Value
4.3 Global Antiviral Drugs Market Value by Type
4.3.1 Global Branded Antiviral Drugs Market by Value
4.3.2 Global Branded Antiviral Drugs Market Forecast by Value
4.3.3 Global Generic Antiviral Drugs Market by Value
4.3.4 Global Generic Antiviral Drugs Market Forecast by Value
4.4 Global Antiviral Drugs Market Value by Application
4.4.1 Global Hepatitis Antiviral Drugs Market by Value
4.4.2 Global Hepatitis Antiviral Drugs Market Forecast by Value
4.4.3 Global HIV Antiviral Drugs Market by Value
4.4.4 Global HIV Antiviral Drugs Market Forecast by Value
4.4.5 Global Influenza Antiviral Drugs Market by Value
4.4.6 Global Influenza Antiviral Drugs Market Forecast by Value
4.4.7 Global Herpes Antiviral Drugs Market by Value
4.4.8 Global Herpes Antiviral Drugs Market Forecast by Value
4.5 Global Antiviral Drugs Market Value by Regions

5. Regional Market Analysis
5.1 North America
5.1.1 North America Antiviral Drugs Market by Value
5.1.2 North America Antiviral Drugs Market Forecast by Value
5.1.3 North America Antiviral Drugs Market by Region
5.1.4 The U.S. Antiviral Drugs Market by Value
5.1.5 The U.S. Antiviral Drugs Market Forecast by Value
5.1.6 The U.S. Antiviral Drugs Market by Type
5.1.7 The U.S. Branded Antiviral Drugs Market by Value
5.1.8 The U.S. Branded Antiviral Drugs Market Forecast by Value
5.1.9 The U.S. Generic Antiviral Drugs Market by Value
5.1.10 The U.S. Generic Antiviral Drugs Market Forecast by Value
5.2 Europe
5.2.1 Europe Antiviral Drugs Market by Value
5.2.2 Europe Antiviral Drugs Market Forecast by Value
5.3 Asia Pacific
5.3.1 Asia Pacific Antiviral Drugs Market by Value
5.3.2 Asia Pacific Antiviral Drugs Market Forecast by Value
5.4 Middle East & Africa
5.4.1 Middle East & Africa Antiviral Drugs Market by Value
5.4.2 Middle East & Africa Antiviral Drugs Market Forecast by Value
5.5 Latin America
5.5.1 Latin America Antiviral Drugs Market by Value
5.5.2 Latin America Antiviral Drugs Market Forecast by Value

6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Prevalence of HIV Infections
6.1.2 Upswing in International Tourism
6.1.3 Growth in Geriatric Population
6.1.4 Increasing Pharmaceutical R&D Spending
6.1.5 Rapid Urbanization
6.1.6 Upsurge in Healthcare Expenditures
6.1.7 Growing Awareness About Various Viral infections and Diseases
6.2 Key Trends and Developments
6.2.1 Accelerating Growth Rates of Infectious Diseases
6.2.2 Increasing Focus on Telehealth
6.2.3 Growth in Pharmaceutical and Biotech Merger & Acquisition
6.2.4 Emergence of Various Pandemic Diseases
6.3 Challenges
6.3.1 High Cost Involved in Drug Development
6.3.2 Threats Associated with Drugs Counterfeiting
6.3.3 Stringent Government Regulations

7. Competitive Landscape
7.1 Global Market
7.1.1 Key Players – Revenue Comparison
7.1.2 Key Players – R&D Expenditure Comparison
7.1.3 Key Players – Market Capitalization Comparison

8. Company Profiles
8.1 Johnson & Johnson
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategies
8.2 Merck and Co.
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategies
8.3 AbbVie Inc.
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategies
8.4 Bristol-Myers Squibb
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategies
8.5 Gilead Sciences
8.5.1 Business Overview
8.5.2 Financial Overview
8.5.3 Business Strategies
8.6 Cipla
8.6.1 Business Overview
8.6.2 Financial Overview
8.6.3 Business Strategies

List of Figures

Viral Life Cycle
Antiviral Agents For Different Indications
Development of Antiviral Drugs
Global Government Share on Health Spending (2019-2024)
Global Antiviral Drugs Market by Value (2015-2019)
Global Antiviral Drugs Market Forecast by Value (2020-2024)
Global Antiviral Drugs Market Value by Type (2019)
Global Branded Antiviral Drugs Market by Value (2015-2019)
Global Branded Antiviral Drugs Market Forecast by Value (2020-2024)
Global Generic Antiviral Drugs Market by Value (2015-2019)
Global Generic Antiviral Drugs Market Forecast by Value (2020-2024)
Global Antiviral Drugs Market Value by Application (2019)
Global Hepatitis Antiviral Drugs Market by Value (2015-2019)
Global Hepatitis Antiviral Drugs Market Forecast by Value (2020-2024)
Global HIV Antiviral Drugs Market by Value (2015-2019)
Global HIV Antiviral Drugs Market Forecast by Value (2020-2024)
Global Influenza Antiviral Drugs Market by Value (2015-2019)
Global Influenza Antiviral Drugs Market Forecast by Value (2020-2024)
Global Herpes Antiviral Drugs Market by Value (2015-2019)
Global Herpes Antiviral Drugs Market Forecast by Value (2020-2024)
Global Antiviral Drugs Market Value by Regions (2019)
North America Antiviral Drugs Market by Value (2015-2019)
North America Antiviral Drugs Market Forecast by Value (2020-2024)
North America Antiviral Drugs Market by Region (2019)
The U.S. Antiviral Drugs Market by Value (2015-2019)
The U.S. Antiviral Drugs Market Forecast by Value (2020-2024)
The U.S. Antiviral Drugs Market by Type (2019)
The U.S. Branded Antiviral Drugs Market by Value (2015-2019)
The U.S. Branded Antiviral Drugs Market Forecast by Value (2020-2024)
The U.S. Generic Antiviral Drugs Market by Value (2015-2019)
The U.S. Generic Antiviral Drugs Market Forecast by Value (2020-2024)
Europe Antiviral Drugs Market by Value (2015-2019)
Europe Antiviral Drugs Market Forecast by Value (2020-2024)
Asia Pacific Antiviral Drugs Market by Value (2015-2019)
Asia Pacific Antiviral Drugs Market Forecast by Value (2020-2024)
Middle East & Africa Antiviral Drugs Market by Value (2015-2019)
Middle East & Africa Antiviral Drugs Market Forecast by Value (2020-2024)
Latin America Antiviral Drugs Market by Value (2015-2019)
Latin America Antiviral Drugs Market Forecast by Value (2020-2024)
Global HIV Infected Population (2015-2019)
Global International Tourist Arrivals (2015-2019)
Global Geriatric Population – Age 65 and Above (2015-2019)
Global Pharmaceutical R&D Spending (2015-2019)
Global Urban Population (2015-2019)
Global Healthcare Expenditure Per Capita (2015-2019)
Global Growth Rate of Infectious Diseases Forecast (2017-2022)
Global Telehealth Patient Population (2015-2019)
Global Pharmaceutical and Biotech M&A (2015-2019)
Johnson & Johnson Total Sales and Net Earnings (2015-2019)
Johnson & Johnson Total Sales by Segments (2019)
Johnson & Johnson Total Sales by Regions (2019)
Merck and Co. Sales and Net Income (2015-2019)
Merck and Co. Sales by Segments (2019)
Merck and Co. Sales by Regions (2019)
AbbVie Inc. Net Revenue and Net Earnings (2015-2019)
AbbVie Inc. Net Revenue by Product (2019)
AbbVie Inc. Net Revenue by Regions (2019)
Bristol-Myers Squibb Total Revenue and Net Earnings (2015-2019)
Bristol-Myers Squibb Total Revenue by Operations (2019)
Bristol-Myers Squibb Total Revenue by Regions (2019)
Gilead Sciences Total Revenue and Net Income (2015-2019)
Gilead Sciences Total Revenue by Operations (2019)
Gilead Sciences Total Revenue by Regions (2019)
Cipla Revenue and Profit (2015-2019)
Cipla Revenue by Segments (2019)
Cipla Revenue by Regions (2019)

List of Tables

Some Major Antiviral Compounds Developed and Approved for Use in Humans
Global COVID-19 Confirmed Deaths
COVID-19 Antiviral Candidate Drugs in Phase III-IV Trials
Major Clinical Studies of Remdesivir
Key Players – Revenue Comparison (2019)
Key Players – R&D Expenditure Comparison (2019)
Key Players – Market Capitalization Comparison (2020)

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs